The conclave was attended by MED-EL global CEO Dr. Ingeborg Hochmair and other healthcare professionals, surgeons and industry experts.
MED-EL India, the Indian subsidiary of the global leading provider of hearing implant systems MED-EL, known for developing innovative products to help patients overcome hearing loss worldwide, today announced the ‘Roadmap and Opportunities for the growth of hearing aid technology and impairment treatments in India in the next decade' basis an industry conclave held in NCR.
The conclave was attended by MED-EL global CEO Dr. Ingeborg Hochmair and other healthcare professionals, surgeons and industry experts to address the needs of the hearing impaired in India.
Tejinder Singh, Director at MED-EL India said, "In India, it is estimated that up to 8.8 per cent of the population suffers from hearing loss with approximately 3.8 million children waiting for cochlear implants. If children are implanted early with a cochlear implant, they can go on to lead a normal life and develop through the education system. Our company vision is to overcome hearing loss as a barrier to communication and quality of life. It is our endeavour at MED-EL to provide a service that is reliable, trustworthy, and offers the very latest in technology to the many millions of Indians who can benefit from a cochlear implant."
Prof. (Dr.) J.M. Hans, Padmashree awardee and renowned surgeon said, "There are more solutions available than ever before to restore the gift of hearing to the Indian people who suffer from various types of hearing loss. Early implantation of children with hearing loss allows them to develop listening and speaking skills and increase their opportunities for the future."
The number of cochlear implantations in India is growing rapidly, with investments from the Government and the increased demand from the Indian population. MED-EL has been a principal supplier for cochlear implants and is supporting government sponsored cochlear implant programs in several states like Tamil Nadu, Kerala, Delhi, Chhattisgarh, Assam, Gujarat and Madhya Pradesh; to name a few. Through the Indian subsidiary, company continues to expand and support 100+ clinics in 45+ major cities in India, Sri Lanka, Nepal and Bangladesh. MED-EL is helping to drive this industry with long-term implant solutions and support that can bring major economic benefits to the country. MED-EL India is positioned not only as a supplier but as a long-term service provider for the entirety of the implant cycle.
No comments:
Post a Comment